{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:10:15Z","timestamp":1789053015899,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20421 and 82171189"],"award-info":[{"award-number":["U23A20421 and 82171189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00406-026-02318-7","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:09:23Z","timestamp":1783148963000},"page":"3605-3622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of xanomeline\u2013trospium on the gut\u2013lung microbiota axis and susceptibility to LPS-induced acute lung injury in male and female mice"],"prefix":"10.1007","volume":"276","author":[{"given":"Xin","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"9","key":"2318_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1176\/appi.ajp.21101083","volume":"179","author":"SM Paul","year":"2022","unstructured":"Paul SM, Yohn SE, Popiolek M, Miller AC, Felder CC (2022) Muscarinic acetylcholine receptor agonists as novel treatments for schizophrenia. Am J Psychiatry 179(9):611\u2013627. https:\/\/doi.org\/10.1176\/appi.ajp.21101083","journal-title":"Am J Psychiatry"},{"issue":"8","key":"2318_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.biopsych.2024.03.014","volume":"96","author":"SM Paul","year":"2024","unstructured":"Paul SM, Yohn SE, Brannan SK, Neugebauer NM, Breier A (2024) Muscarinic receptor activators as novel treatments for schizophrenia. Biol Psychiatry 96(8):627\u2013637. https:\/\/doi.org\/10.1016\/j.biopsych.2024.03.014","journal-title":"Biol Psychiatry"},{"issue":"10422","key":"2318_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0140-6736(23)02190-6","volume":"403","author":"I Kaul","year":"2024","unstructured":"Kaul I, Sawchak S, Correll CU, Kakar R, Breier A, Zhu H et al (2024) Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial. Lancet 403(10422):160\u2013170. https:\/\/doi.org\/10.1016\/S0140-6736(23)02190-6","journal-title":"Lancet"},{"issue":"8","key":"2318_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamapsychiatry.2024.0785","volume":"81","author":"I Kaul","year":"2024","unstructured":"Kaul I, Sawchak S, Walling DP, Tamminga CA, Breier A, Zhu H et al (2024) Efficacy and safety of xanomeline-trospium chloride in schizophrenia: a randomized clinical trial. JAMA Psychiat 81(8):749\u2013756. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.0785","journal-title":"JAMA Psychiat"},{"issue":"8033","key":"2318_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/d41586-024-03123-9","volume":"634","author":"E Dolgin","year":"2024","unstructured":"Dolgin E (2024) Revolutionary drug for schizophrenia wins US approval. Nature 634(8033):276\u2013277. https:\/\/doi.org\/10.1038\/d41586-024-03123-9","journal-title":"Nature"},{"issue":"1","key":"2318_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldaf016","volume":"156","author":"M Lyman","year":"2025","unstructured":"Lyman M, McCutcheon RA (2025) Antipsychotic drugs at 75: the past, present, and future of psychosis management. Br Med Bull 156(1):ldaf016. https:\/\/doi.org\/10.1093\/bmb\/ldaf016","journal-title":"Br Med Bull"},{"issue":"8","key":"2318_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa201701","volume":"384","author":"SK Brannan","year":"2021","unstructured":"Brannan SK, Sawchak S, Miller AC, Lieberman JA, Paul SM, Breier A (2021) Muscarinic cholinergic receptor agonist and peripheral antagonist for schizophrenia. N Engl J Med 384(8):717\u2013726. https:\/\/doi.org\/10.1056\/NEJMoa201701","journal-title":"N Engl J Med"},{"issue":"1","key":"2318_CR8","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.24m15497","volume":"86","author":"I Kaul","year":"2025","unstructured":"Kaul I, Claxton A, Sawchak S, Sauder C, Brannan SK, Raj E et al (2025) Safety and tolerability of Xanomeline and Trospium Chloride in schizophrenia: pooled results from the 5-week, randomized, double-blind, placebo-controlled EMERGENT trials. J Clin Psychiatry 86(1):24m15497. https:\/\/doi.org\/10.4088\/JCP.24m15497","journal-title":"J Clin Psychiatry"},{"key":"2318_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.schres.2025.12.015","volume":"288","author":"I Kaul","year":"2026","unstructured":"Kaul I, Claxton A, Chaturvedi S, Patel T, Wu H, Sawchak S et al (2026) Long-term efficacy, safety, and tolerability of xanomeline and trospium chloride in schizophrenia: a 52-week, open-label trial (EMERGENT-5). Schizophr Res 288:86\u201394. https:\/\/doi.org\/10.1016\/j.schres.2025.12.015","journal-title":"Schizophr Res"},{"issue":"9","key":"2318_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1056\/NEJM200103013440908","volume":"344","author":"PE Marik","year":"2001","unstructured":"Marik PE (2001) Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344(9):665\u2013671. https:\/\/doi.org\/10.1056\/NEJM200103013440908","journal-title":"N Engl J Med"},{"issue":"5","key":"2318_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","volume":"9","author":"JB Furness","year":"2012","unstructured":"Furness JB (2012) The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9(5):286\u2013294. https:\/\/doi.org\/10.1038\/nrgastro.2012.32","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"2318_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jcrc.2014.07.011","volume":"30","author":"DM DiBardino","year":"2015","unstructured":"DiBardino DM, Wunderink RG (2015) Aspiration pneumonia: a review of modern trends. J Crit Care 30(1):40\u201348. https:\/\/doi.org\/10.1016\/j.jcrc.2014.07.011","journal-title":"J Crit Care"},{"issue":"11","key":"2318_CR13","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1177\/02698811251365177","volume":"39","author":"GP Reynolds","year":"2025","unstructured":"Reynolds GP (2025) The pharmacology underlying the unique antipsychotic efficacy of clozapine. J Psychopharmacol 39(11):1209\u20131212. https:\/\/doi.org\/10.1177\/02698811251365177","journal-title":"J Psychopharmacol"},{"issue":"6","key":"2318_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00714","volume":"22","author":"C Zhuo","year":"2025","unstructured":"Zhuo C, Li C, Tian H, Wang L, Ma X, Li R et al (2025) Shared and unique therapeutic targets of KarXT and clozapine for schizophrenia treatment revealed by network pharmacology and molecular docking analyses: implications for differential clinical responses. Neurotherapeutics 22(6):e00714. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00714","journal-title":"Neurotherapeutics"},{"issue":"2","key":"2318_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2019-100183","volume":"33","author":"J de Leon","year":"2020","unstructured":"de Leon J, Ruan CJ, Verdoux H, Wang C (2020) Clozapine is strongly associated with the risk of pneumonia and inflammation. Gen Psychiatry 33(2):e100183. https:\/\/doi.org\/10.1136\/gpsych-2019-100183","journal-title":"Gen Psychiatry"},{"issue":"10","key":"2318_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1176\/appi.ajp.20230744","volume":"181","author":"JJ Partanen","year":"2024","unstructured":"Partanen JJ, H\u00e4pp\u00f6l\u00e4 P, K\u00e4mpe A, Ahola-Olli A, Hellsten A, Rask SM et al (2024) High burden of ileus and pneumonia in clozapine-treated individuals with schizophrenia: a Finnish 25-year follow-up register study. Am J Psychiatry 181(10):879\u2013892. https:\/\/doi.org\/10.1176\/appi.ajp.20230744","journal-title":"Am J Psychiatry"},{"issue":"10","key":"2318_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1176\/appi.ajp.20240778","volume":"181","author":"KNR Chengappa","year":"2024","unstructured":"Chengappa KNR, Cotes RO (2024) Clozapine\u2019s high incidence of ileus and pneumonia demand better clinical strategies-how do we get there? Am J Psychiatry 181(10):851\u2013853. https:\/\/doi.org\/10.1176\/appi.ajp.20240778","journal-title":"Am J Psychiatry"},{"key":"2318_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.schres.2023.09.029","volume":"268","author":"N Kang","year":"2024","unstructured":"Kang N, Kim SH, Kim J, Kim S, Jang J, Yoon H et al (2024) Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital. Schizophr Res 268:107\u2013113. https:\/\/doi.org\/10.1016\/j.schres.2023.09.029","journal-title":"Schizophr Res"},{"issue":"8","key":"2318_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/17425255.2024.2373111","volume":"20","author":"J de Leon","year":"2024","unstructured":"de Leon J, Ruan CJ, Schoretsanitis G, Villasante-Tezanos AG, Spina E, Sanz EJ et al (2024) Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia. Expert Opin Drug Metab Toxicol 20(8):857\u2013871. https:\/\/doi.org\/10.1080\/17425255.2024.2373111","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2318_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2025.03.014","volume":"278","author":"HC Huang","year":"2025","unstructured":"Huang HC, Wu BJ, Yu CH, Liu CZ, Wu LS (2025) LEPR gene polymorphisms and pneumonia risk in Taiwanese schizophrenia patients under clozapine treatment. Schizophr Res 278:1\u20138. https:\/\/doi.org\/10.1016\/j.schres.2025.03.014","journal-title":"Schizophr Res"},{"issue":"12","key":"2318_CR21","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.3390\/medicina60122016","volume":"60","author":"V Zhao","year":"2024","unstructured":"Zhao V, Gong Y, Thomas N, Das S (2024) Clozapine and pneumonia: synthesizing the link by reviewing existing reports-a systematic review and meta-Analysis. Medicina (Kaunas) 60(12):2016. https:\/\/doi.org\/10.3390\/medicina60122016","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"2318_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1192\/bjp.2024.255","volume":"227","author":"K Hashimoto","year":"2025","unstructured":"Hashimoto K (2025) Host microbiota in clozapine-induced ileus and pneumonia among people with schizophrenia. Br J Psychiatry 227(2):574\u2013575. https:\/\/doi.org\/10.1192\/bjp.2024.255","journal-title":"Br J Psychiatry"},{"issue":"11","key":"2318_CR23","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1038\/s41380-019-0475-4","volume":"25","author":"F Zhu","year":"2020","unstructured":"Zhu F, Guo R, Wang W, Ju Y, Wang Q, Ma Q et al (2020) Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice. Mol Psychiatry 25(11):2905\u20132918. https:\/\/doi.org\/10.1038\/s41380-019-0475-4","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2318_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15457-9","volume":"11","author":"F Zhu","year":"2020","unstructured":"Zhu F, Ju Y, Wang W, Wang Q, Guo R, Ma Q et al (2020) Metagenome-wide association of gut microbiome features for schizophrenia. Nat Commun 11(1):1612. https:\/\/doi.org\/10.1038\/s41467-020-15457-9","journal-title":"Nat Commun"},{"issue":"4","key":"2318_CR25","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41380-022-01456-3","volume":"27","author":"AJ McGuinness","year":"2022","unstructured":"McGuinness AJ, Davis JA, Dawson SL, Loughman A, Collier F, O\u2019Hely M et al (2022) A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry 27(4):1920\u20131935. https:\/\/doi.org\/10.1038\/s41380-022-01456-3","journal-title":"Mol Psychiatry"},{"issue":"9","key":"2318_CR26","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41380-023-02287-6","volume":"28","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K (2023) Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions. Mol Psychiatry 28(9):3625\u20133637. https:\/\/doi.org\/10.1038\/s41380-023-02287-6","journal-title":"Mol Psychiatry"},{"issue":"4","key":"2318_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00058-23","volume":"11","author":"L Qian","year":"2023","unstructured":"Qian L, He X, Liu Y, Gao F, Lu W, Fan Y et al (2023) Longitudinal gut microbiota dysbiosis underlies olanzapine-induced weight gain. Microbiol Spectr 11(4):e0005823. https:\/\/doi.org\/10.1128\/spectrum.00058-23","journal-title":"Microbiol Spectr"},{"issue":"2","key":"2318_CR28","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/ijms22020926","volume":"22","author":"Y Tanahashi","year":"2021","unstructured":"Tanahashi Y, Komori S, Matsuyama H, Kitazawa T, Unno T (2021) Functions of muscarinic receptor subtypes in gastrointestinal smooth muscle: a review of studies with receptor-knockout mice. Int J Mol Sci 22(2):926. https:\/\/doi.org\/10.3390\/ijms22020926","journal-title":"Int J Mol Sci"},{"key":"2318_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-3-642-23274-9_15","volume":"208","author":"FJ Ehlert","year":"2012","unstructured":"Ehlert FJ, Pak KJ, Griffin MT (2012) Muscarinic agonists and antagonists: effects on gastrointestinal function. Handb Exp Pharmacol 208:343\u2013374. https:\/\/doi.org\/10.1007\/978-3-642-23274-9_15","journal-title":"Handb Exp Pharmacol"},{"issue":"7","key":"2318_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076508","volume":"24","author":"J Uwada","year":"2023","unstructured":"Uwada J, Nakazawa H, Muramatsu I, Masuoka T, Yazawa T (2023) Role of muscarinic acetylcholine receptors in intestinal epithelial homeostasis: insights for the treatment of inflammatory bowel disease. Int J Mol Sci 24(7):6508. https:\/\/doi.org\/10.3390\/ijms24076508","journal-title":"Int J Mol Sci"},{"key":"2318_CR31","doi-asserted-by":"publisher","unstructured":"Ding X, Murayama R, Cai Y, Yue Y, Yang J, Hashimoto K (2026) Xanomeline-trospium reverses phencyclidine-induced cognitive deficits through modulation of the gut microbiota-brain axis in mice. Psychiatry in press, Transl https:\/\/doi.org\/10.1038\/s41398-026-04097-0","DOI":"10.1038\/s41398-026-04097-0"},{"key":"2318_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120885","volume":"307","author":"Y Hashimoto","year":"2022","unstructured":"Hashimoto Y, Eguchi A, Wei Y, Shinno-Hashimoto H, Fujita Y, Ishima T et al (2022) Antibiotic-induced microbiome depletion improves LPS-induced acute lung injury via gut-lung axis. Life Sci 307:120885. https:\/\/doi.org\/10.1016\/j.lfs.2022.120885","journal-title":"Life Sci"},{"key":"2318_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2025.100966","volume":"44","author":"D Xu","year":"2025","unstructured":"Xu D, Zhao M, Liu G, Zhu T, Cai Y, Murayama R et al (2025) The vagus nerve-dependent lung-brain axis mediates brain demyelination following acute lung injury. Brain Behav Immun Health 44:100966. https:\/\/doi.org\/10.1016\/j.bbih.2025.100966","journal-title":"Brain Behav Immun Health"},{"key":"2318_CR34","doi-asserted-by":"publisher","unstructured":"Cai Y, Eguchi A, Murayama R, Ding X, Yue Y, Niitsu T, Oda Y, Futamura T, Yang J, Nakamura H, Hashimoto K (2026) Clozapine-induced microbiota dysbiosis links gastrointestinal hypomotility to increased respiratory vulnerability. Transl Psychiatry in press. https:\/\/doi.org\/10.1038\/s41398-026-04077-4","DOI":"10.1038\/s41398-026-04077-4"},{"issue":"4","key":"2318_CR35","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1080\/19490976.2019.1701352","volume":"11","author":"J Triplett","year":"2020","unstructured":"Triplett J, Ellis D, Braddock A, Roberts E, Ingram K, Perez E et al (2020) Temporal and region-specific effects of sleep fragmentation on gut microbiota and intestinal morphology in Sprague Dawley rats. Gut Microbes 11(4):706\u2013720. https:\/\/doi.org\/10.1080\/19490976.2019.1701352","journal-title":"Gut Microbes"},{"key":"2318_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111223","volume":"136","author":"D Xu","year":"2025","unstructured":"Xu D, Eguchi A, Murayama R, Liu G, Zhao M, Zhu T et al (2025) Effects of 3,4-methylenedioxymethamphetamine on the gut microbiota and metabolites in the small intestine, cecum, and colon of male rats. Prog Neuropsychopharmacol Biol Psychiatry 136:111223. https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111223","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2318_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177345","volume":"991","author":"M Zhao","year":"2025","unstructured":"Zhao M, Eguchi A, Murayama R, Xu D, Zhu T, Xu B et al (2025) Repeated intermittent administration of 3,4-methylenedioxymethamphetamine mitigates demyelination in the brain from cuprizone-treated mice. Eur J Pharmacol 991:177345. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177345","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"2318_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS et al (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12(6):R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60","journal-title":"Genome Biol"},{"issue":"4","key":"2318_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.9758\/cpn.25.1309","volume":"23","author":"X Wan","year":"2025","unstructured":"Wan X, Eguchi A, Murayama R, Mori C, Hashimoto K (2025) Intermittent MDMA attenuates ovariectomy-induced bone loss via a gut microbiota-bone axis. Clin Psychopharmacol Neurosci 23(4):668\u2013682. https:\/\/doi.org\/10.9758\/cpn.25.1309","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2318_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54137-w","volume":"15","author":"H Takeda","year":"2024","unstructured":"Takeda H, Matsuzawa Y, Takeuchi M, Takahashi M, Nishida K, Harayama T et al (2024) MS-DIAL 5 multimodal mass spectrometry data mining unveils lipidome complexities. Nat Commun 15:9903. https:\/\/doi.org\/10.1038\/s41467-024-54137-w","journal-title":"Nat Commun"},{"key":"2318_CR41","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1021\/es5002105","volume":"48","author":"EL Schymanski","year":"2014","unstructured":"Schymanski EL, Jeon J, Gulde R, Fenner K, Ruff M, Singer HP et al (2014) Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol 48:2097\u20132098. https:\/\/doi.org\/10.1021\/es5002105","journal-title":"Environ Sci Technol"},{"issue":"1","key":"2318_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrmicro3552","volume":"14","author":"GP Donaldson","year":"2016","unstructured":"Donaldson GP, Lee SM, Mazmanian SK (2016) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14(1):20\u201332. https:\/\/doi.org\/10.1038\/nrmicro3552","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2318_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.chom.2017.03.010","volume":"21","author":"C Tropini","year":"2017","unstructured":"Tropini C, Earle KA, Huang KC, Sonnenburg JL (2017) The gut microbiome: connecting spatial organization to function. Cell Host Microbe 21(4):433\u2013442. https:\/\/doi.org\/10.1016\/j.chom.2017.03.010","journal-title":"Cell Host Microbe"},{"key":"2318_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101190","author":"BAH Jensen","year":"2023","unstructured":"Jensen BAH, Heyndrickx M, Jonkers D, Mackie A, Millet S, Naghibi M et al (2023) Small intestine vs colon ecology and physiology: Why it matters in probiotic administration. Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101190","journal-title":"Cell Rep Med"},{"issue":"12","key":"2318_CR45","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrgastro.2013.180","volume":"10","author":"JB Furness","year":"2013","unstructured":"Furness JB, Rivera LR, Cho HJ, Bravo DM, Callaghan B (2013) The gut as a sensory organ. Nat Rev Gastroenterol Hepatol 10(12):729\u2013740. https:\/\/doi.org\/10.1038\/nrgastro.2013.180","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"2318_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3444","volume":"20","author":"A Trompette","year":"2014","unstructured":"Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C et al (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20(2):159\u2013166. https:\/\/doi.org\/10.1038\/nm.3444","journal-title":"Nat Med"},{"issue":"6","key":"2318_CR47","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165(6):1332\u20131345. https:\/\/doi.org\/10.1016\/j.cell.2016.05.041","journal-title":"Cell"},{"issue":"1","key":"2318_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","volume":"15","author":"KF Budden","year":"2017","unstructured":"Budden KF, Gellatly SL, Wood DL, Cooper MA, Morrison M, Hugenholtz P et al (2017) Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol 15(1):55\u201363. https:\/\/doi.org\/10.1038\/nrmicro.2016.142","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2318_CR49","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","volume":"12","author":"AT Dang","year":"2019","unstructured":"Dang AT, Marsland BJ (2019) Microbes, metabolites, and the gut-lung axis. Mucosal Immunol 12(4):843\u2013850. https:\/\/doi.org\/10.1038\/s41385-019-0160-6","journal-title":"Mucosal Immunol"},{"key":"2318_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","volume":"10","author":"R Enaud","year":"2020","unstructured":"Enaud R, Prevel R, Ciarlo E, Beaufils F, Wie\u00ebrs G, Guery B et al (2020) The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol 10:9. https:\/\/doi.org\/10.3389\/fcimb.2020.00009","journal-title":"Front Cell Infect Microbiol"},{"issue":"6123","key":"2318_CR51","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U et al (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339(6123):1084\u20131088. https:\/\/doi.org\/10.1126\/science.1233521","journal-title":"Science"},{"issue":"4","key":"2318_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/19490976.2016.1203502","volume":"7","author":"E Org","year":"2016","unstructured":"Org E, Mehrabian M, Parks BW, Shipkova P, Liu X, Drake TA et al (2016) Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes 7(4):313\u2013322. https:\/\/doi.org\/10.1080\/19490976.2016.1203502","journal-title":"Gut Microbes"},{"issue":"10","key":"2318_CR53","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626\u2013638. https:\/\/doi.org\/10.1038\/nri.2016.90","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2318_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/1040841X.2016.1176988","volume":"43","author":"Y He","year":"2017","unstructured":"He Y, Wen Q, Yao F, Xu D, Huang Y, Wang J (2017) Gut-lung axis: the microbial contributions and clinical implications. Crit Rev Microbiol 43(1):81\u201395. https:\/\/doi.org\/10.1080\/1040841X.2016.1176988","journal-title":"Crit Rev Microbiol"},{"issue":"9","key":"2318_CR55","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM et al (2021) The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 18(9):649\u2013667. https:\/\/doi.org\/10.1038\/s41575-021-00440-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"2318_CR56","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1038\/s41380-023-02161-5","volume":"28","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K (2023) Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein-Barr virus and the gut-brain axis. Mol Psychiatry 28(12):4968\u20134976. https:\/\/doi.org\/10.1038\/s41380-023-02161-5","journal-title":"Mol Psychiatry"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-026-02318-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-026-02318-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-026-02318-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:49:30Z","timestamp":1789051770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-026-02318-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2318"],"URL":"https:\/\/doi.org\/10.1007\/s00406-026-02318-7","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Hashimoto has received research support from Otsuka (Tokyo, Japan). The other authors declare no competing interests related to this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}